Tag - ALLR

Developments

Allarity secures first commercial agreement under new CLIA laboratory services strategy

Allarity Therapeutics (NASDAQ: ALLR) has announced its first revenue-generating contract under its newly established Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory services strategy, which is...

October 30, 2026

Executive Moves

Jeff Ervin joins Allarity as CFO

Allarity Therapeutics (NASDAQ: ALLR) has announced the appointment of Jeff Ervin as chief financial officer (CFO), succeeding Alexander Epshinsky, who will remain involved during the transition period. Mr. Ervin brings...

July 7, 2025

Tag - ALLR

Allarity secures first commercial agreement under new CLIA laboratory services strategy

Jeff Ervin joins Allarity as CFO

Subscribe